Investor profile
Sunstone Life Science Ventures has backed 5 European tech companies across 6 funding rounds between 2020 and 2024, joining rounds totalling €183M. Most active in Healthtech. Data as of 7 Aug 2026.
Also recorded as: Sunstone LifeScience Ventures
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| MinervaX | Denmark | 2 | €76M |
| TargED Biopharmaceutical | Netherlands | 1 | €39M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
| Synendos Therapeutics | Switzerland | 1 | €19M |
| Resalis Therapeutics |
| Company | Stage | Amount | Date |
|---|---|---|---|
| MinervaX | Other | €54M | 2023-10 |
| TargED Biopharmaceutical | Series A | €39M | 2022-02 |
| TargED Biopharmaceuticals | Series A | €39M | 2022-02 |
| MinervaX |
| Italy |
| 1 |
| €10M |
| Other |
| €22M |
| 2022-12 |
| Synendos Therapeutics | Series A | €19M | 2020-11 |
| Resalis Therapeutics | Series A | €10M | 2024-01 |
